Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Have Psoriasis? Here???s What You Need to Know Before Your Next Cosmetic Treatment
38+ min ago (334+ words) Have Psoriasis? Here’s What You Need to Know Before Your Next Cosmetic Treatment NewBeauty Psoriasis can be a very frustrating skin condition. With severity varying from person to person—from plaque location and medications used to flare frequency—these factors…...
TO YOUR GOOD HEALTH: Dermatologist prescribes metformin for woman's skin rash
4+ hour, 21+ min ago (296+ words) DEAR DR. ROACH: I have a skin rash (granuloma annulare), and my dermatologist said that there really isnât a cure for it. Itâs in various areas of my body â my upper back, my trunk (mostly in areas…...
Chasing Dupixent, a biotech aims to make better antibody drugs for eczema
1+ hour, 12+ min ago (508+ words) Infinimmune, a California startup, is developing treatments it claims might last longer and be more effective than existing atopic dermatitis medications. Dupixent, a drug cleared for eczema and many other autoimmune conditions, is one of the world’s best-selling medicines. But…...
St. Louis Dermatology & Cosmetic Surgery Ranks No. 2219 on 2026 Inc. 5000 List of America’s Fastest-Growing Companies
1+ hour, 9+ min ago (152+ words) There were 1,243 press releases posted in the last 24 hours and 269,209 in the last 365 days. St. Louis Dermatology & Cosmetic Surgery is a leading provider of Mohs micrographic surgery, medical dermatology, and cosmetic dermatology. Dr. Brandon T. Beal, MD, FAAD specializes in IHC-assisted…...
Victor Moreno?? FDA Approves RP1 Plus Nivolumab for PD-1-Refractory Melanoma
2+ hour, 58+ min ago (99+ words) Victor Moreno, Director Clinical Research at START Madrid FJD, shared on LinkedIn: “Oncolytic immunotherapy has reached a major milestone. RP1 plus nivolumab is now FDA-approved for PD-1-refractory melanoma, with durable responses seen beyond the injected lesions. The accelerated approval is…...
Mathematical Modeling Could Balance Tumor Control and Treatment Toxicity in Melanoma
3+ hour, 44+ min ago (318+ words) New research from The University of Texas at Arlington helps explain a longstanding puzzle in melanoma treatment: why continuous targeted therapy performed better than planned on-and-off treatment schedules in clinical trials, despite promising laboratory studies of intermittent dosing. “Reducing toxicity…...
Infinimmune bags $75M for atopic dermatitis antibody duo
3+ hour, 13+ min ago (10+ words) FirstWord PHARMA...
Watch 9News Latest Stories - Season 2026 - Dermatologists outnumbered by eczema patients, data reveals
4+ hour, 14+ min ago (14+ words) 9Now...
'A sponge for the sun's rays': Certain medicines increase sunburn
4+ hour, 4+ min ago (428+ words) 12.17 11 Aug 2026 People have been warned that a number of everyday household medicines act “like a sponge for the sun's rays” and increase the rate at which people suffer from sunburn. With yet more sunny weather forecast for this week, people…...